Our results suggest that inhibition of FKBP4 induces a cell cycle arrest in triple-negative breast cancer cells through down-regulation of the PI3K/Akt signaling activity, resulting in Cyclin D1 downregulation. Here, FKBP4 is linked to triple-negative breast carcinoma.